Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Raoul Poupon, Olivier Chazouillères et al.|New England Journal of Medicine|2018Cited by 605
Origin, HDV genotype and persistent viremia determine outcome and treatment response in patients with chronic hepatitis deltaDominique Roulot, Sophie Hillaire, Ségolène Brichler et al.|Journal of Hepatology|2020Cited by 151